Author, Dr Fiona MacRae, a specialist in integrative women’s health and bioidentical hormone balancing for the Marion Gluck Clinic, discusses the role of bioidentical hormone replacement in postpartum recovery
The postpartum period, often referred to as the “fourth trimester”, marks a time of profound biological, psychological, and emotional transition for women. While medical attention during this stage frequently centres on obstetric complications, breastfeeding support, and neonatal care, the mother’s endocrine recovery is often overlooked. Yet, for many women, the dramatic withdrawal of reproductive hormones following placental expulsion precipitates a range of debilitating symptoms, including mood instability, fatigue, cognitive dysfunction, and urogenital complaints.
For a select group of postpartum women, particularly those experiencing moderate to severe hormonal withdrawal symptoms, bioidentical hormone replacement therapy (BHRT) may offer a physiologically congruent and clinically meaningful intervention. While not part of standard postnatal care guidelines, growing clinical interest and early research suggest BHRT could serve as a valuable adjunct in managing postpartum neuroendocrine imbalance.
Hormonal shifts after delivery
During pregnancy, the placenta acts as a powerful endocrine organ, producing vast quantities of estradiol, progesterone, and human chorionic gonadotropin (hCG), among others. Estradiol levels rise more than 100-fold above non-pregnant levels, and progesterone surges to maintain uterine quiescence, immune tolerance, and neurosteroid balance. Testosterone, while modestly elevated during pregnancy, tends to drop postpartum, often below baseline.
Following placental expulsion, estrogen and progesterone levels fall precipitously within hours—a hormonal crash unparalleled in its speed and magnitude in any other physiological state. DHEA and testosterone levels may remain suppressed for weeks to months, particularly in breastfeeding women, whose hypothalamic-pituitary-ovarian (HPO) axis is further inhibited by prolactin and oxytocin signalling.
These abrupt hormonal shifts are not merely biochemical phenomena,they have significant clinical implications:
- Estrogen withdrawal is linked with vasomotor symptoms (e.g. night sweats, hot flushes), vaginal dryness, dysphoria, and a reduction in serotonergic tone.
- Progesterone withdrawal contributes to sleep disturbances, irritability, and anxiety through its role in GABA-A receptor modulation.
- Androgen decline, especially DHEA and testosterone, may underlie postpartum fatigue, loss of libido, muscle catabolism, and reduced cognitive drive.
Clinically, this endocrine profile mimics perimenopause or surgical menopause, albeit in an acutely condensed timeframe. The degree of symptomatic burden varies widely, and some women may remain asymptomatic, while others experience debilitating symptoms that impact maternal-infant bonding, emotional wellbeing, and overall recovery.
What is BHRT?
Bioidentical hormone replacement therapy involves the use of hormones that are structurally identical to those produced endogenously by the human body. This typically includes:
- 17β-estradiol (transdermal or sublingual formulations)
- Micronized progesterone (oral or transdermal)
- DHEA or testosterone (transdermal -Te